APACHE-IV
Cross-source consensus on APACHE-IV from 1 sources and 4 claims.
1 sources · 4 claims
How it works
Risks & contraindications
Highlighted claims
- The study recalibrated APACHE-IV using logistic regression with hospital death as the outcome. — Mortality differences between ICUs that are regarded as ‘in control’: a longitudinal register-based study in the Netherlands, 2013–2023
- APACHE-IV recalibration was performed separately for CABG and non-CABG patients because different APACHE-IV models apply to those groups. — Mortality differences between ICUs that are regarded as ‘in control’: a longitudinal register-based study in the Netherlands, 2013–2023
- APACHE-IV accounts for illness severity and case mix in expected mortality estimates. — Mortality differences between ICUs that are regarded as ‘in control’: a longitudinal register-based study in the Netherlands, 2013–2023
- APACHE-IV case-mix adjustment remains imperfect because it lacks some domain-specific predictors and comorbidities. — Mortality differences between ICUs that are regarded as ‘in control’: a longitudinal register-based study in the Netherlands, 2013–2023